Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) makes a major impact on morbidity and mortality among the workingage population in developed countries. In the lack of effective pharmacological methods, the leading role in treatment of NAFLD belongs to lifestyle modification, consistent and gradual weight l...

Full description

Bibliographic Details
Main Authors: K. A. Andreev, Yu. P. Skirdenko, N. A. Nikolaev, M. A. Livzan, A. V. Gorbenko, M. M. Fedorin, T. S. Krolevets
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2022-01-01
Series:Бюллетень сибирской медицины
Subjects:
Online Access:https://bulletin.ssmu.ru/jour/article/view/4588
_version_ 1797872807280902144
author K. A. Andreev
Yu. P. Skirdenko
N. A. Nikolaev
M. A. Livzan
A. V. Gorbenko
M. M. Fedorin
T. S. Krolevets
author_facet K. A. Andreev
Yu. P. Skirdenko
N. A. Nikolaev
M. A. Livzan
A. V. Gorbenko
M. M. Fedorin
T. S. Krolevets
author_sort K. A. Andreev
collection DOAJ
description Nonalcoholic fatty liver disease (NAFLD) makes a major impact on morbidity and mortality among the workingage population in developed countries. In the lack of effective pharmacological methods, the leading role in treatment of NAFLD belongs to lifestyle modification, consistent and gradual weight loss, and its maintenance. The qualitative and quantitative structure of the diet, intensity of physical activity, and most importantly, regularity and consistency of implementation of lifestyle modification activities are the key to successful management of patients with NAFLD.To date, there are very few studies on adherence to lifestyle modification activities in this group of patients, which is mainly due to a deficiency of methodological tools. The questionnaire “QAA-25” recommended by the Russian Scientific Medical Society of Therapists for quantitative assessment of adherence to treatment allows to assess both adherence to therapy in general and adherence to its individual components (adherence to drug therapy, adherence to medical counseling, and adherence to lifestyle modification), which requires further study taking into account features of therapeutic strategies in treating NAFLD.
first_indexed 2024-04-10T01:04:57Z
format Article
id doaj.art-19a0ec07be5b4a9498d73e1d683f62f5
institution Directory Open Access Journal
issn 1682-0363
1819-3684
language English
last_indexed 2024-04-10T01:04:57Z
publishDate 2022-01-01
publisher Siberian State Medical University (Tomsk)
record_format Article
series Бюллетень сибирской медицины
spelling doaj.art-19a0ec07be5b4a9498d73e1d683f62f52023-03-13T09:58:27ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842022-01-0120411212210.20538/1682-0363-2021-4-112-1222847Adherence to lifestyle modification in patients with nonalcoholic fatty liver diseaseK. A. Andreev0Yu. P. Skirdenko1N. A. Nikolaev2M. A. Livzan3A. V. Gorbenko4M. M. Fedorin5T. S. Krolevets6Омский государственный медицинский университет (ОмГМУ)Омский государственный медицинский университет (ОмГМУ)Омский государственный медицинский университет (ОмГМУ)Омский государственный медицинский университет (ОмГМУ)Омский государственный медицинский университет (ОмГМУ)Омский государственный медицинский университет (ОмГМУ)Омский государственный медицинский университет (ОмГМУ)Nonalcoholic fatty liver disease (NAFLD) makes a major impact on morbidity and mortality among the workingage population in developed countries. In the lack of effective pharmacological methods, the leading role in treatment of NAFLD belongs to lifestyle modification, consistent and gradual weight loss, and its maintenance. The qualitative and quantitative structure of the diet, intensity of physical activity, and most importantly, regularity and consistency of implementation of lifestyle modification activities are the key to successful management of patients with NAFLD.To date, there are very few studies on adherence to lifestyle modification activities in this group of patients, which is mainly due to a deficiency of methodological tools. The questionnaire “QAA-25” recommended by the Russian Scientific Medical Society of Therapists for quantitative assessment of adherence to treatment allows to assess both adherence to therapy in general and adherence to its individual components (adherence to drug therapy, adherence to medical counseling, and adherence to lifestyle modification), which requires further study taking into account features of therapeutic strategies in treating NAFLD.https://bulletin.ssmu.ru/jour/article/view/4588неалкогольная жировая болезнь печениприверженностьмодификация образа жизниинсулинорезистентностьметаболический синдром
spellingShingle K. A. Andreev
Yu. P. Skirdenko
N. A. Nikolaev
M. A. Livzan
A. V. Gorbenko
M. M. Fedorin
T. S. Krolevets
Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease
Бюллетень сибирской медицины
неалкогольная жировая болезнь печени
приверженность
модификация образа жизни
инсулинорезистентность
метаболический синдром
title Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease
title_full Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease
title_fullStr Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease
title_full_unstemmed Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease
title_short Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease
title_sort adherence to lifestyle modification in patients with nonalcoholic fatty liver disease
topic неалкогольная жировая болезнь печени
приверженность
модификация образа жизни
инсулинорезистентность
метаболический синдром
url https://bulletin.ssmu.ru/jour/article/view/4588
work_keys_str_mv AT kaandreev adherencetolifestylemodificationinpatientswithnonalcoholicfattyliverdisease
AT yupskirdenko adherencetolifestylemodificationinpatientswithnonalcoholicfattyliverdisease
AT nanikolaev adherencetolifestylemodificationinpatientswithnonalcoholicfattyliverdisease
AT malivzan adherencetolifestylemodificationinpatientswithnonalcoholicfattyliverdisease
AT avgorbenko adherencetolifestylemodificationinpatientswithnonalcoholicfattyliverdisease
AT mmfedorin adherencetolifestylemodificationinpatientswithnonalcoholicfattyliverdisease
AT tskrolevets adherencetolifestylemodificationinpatientswithnonalcoholicfattyliverdisease